-
Oct 2, 2025, 07:40
by
Ripston helps B2B clinical trial startups build strategic foundations, achieve product-market fit, balance authenticity with AI adoption, and expand to new markets.
Full story
-
Oct 2, 2025, 01:00
by
User Not Found
Clinical Research News | In a food system that prioritizes profits and quantity over nutritional quality, most babies born today lack the gut microbes they need before kindergarten to train their immune system. Persephone Biome, a California-based biotech company, is tackling this issue with its latest product, the Daily Synergistic Synbiotic.
Full story
-
Oct 1, 2025, 08:40
by
Quantabio launched the sparQ Lysis Kit, a flexible solution that delivers high-quality, double-stranded genomic DNA from DBS punches in under 50 minutes.
Full story
-
Oct 1, 2025, 08:40
by
Full story
-
Oct 1, 2025, 08:40
by
PromoCell GmbH has announced its entry into the Good Manufacturing Practice field.
Full story
-
Oct 1, 2025, 08:40
by
Novel Nano-Amorphous Mineral-Based Therapy Shows Meaningful Clinical Improvement and Remission in Patients with Moderate-to-Severe Disease
Full story
-
Sep 30, 2025, 08:44
by
Full story
-
Sep 30, 2025, 08:44
by
Full story
-
Sep 30, 2025, 01:01
by
User Not Found
Clinical Research News | The clinical research industry is awash in new data streams. With the rise of wearables, sensors, and smartphone-based assessments, objective digital measures are increasingly complementing traditional patient-reported outcomes. But should these endpoints be combined, or is it better to keep them separate? A recent SCOPE 365 ClinEco Connect session brought together experts and industry participants to wrestle with this question.
Full story
-
Sep 26, 2025, 08:44
by
ClearNote Health Receives UKCA markings for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test
Full story
-
Sep 25, 2025, 08:58
by
Nonprofit Awards Grants to Projects Focused on Moving Research Forward for Rare Bone Cancer Patients
Full story
-
Sep 25, 2025, 08:58
by
Takara Bio Europe announces the launch of Cellartis® MSC EV Wonder.
Full story
-
Sep 25, 2025, 01:01
by
User Not Found
Clinical Research News | nPhase launches the first industry platform to harmonize real-world evidence and clinical trial data in one system; N-Power Medicine and VieCure have entered a strategic partnership; and more.
Full story
-
Sep 24, 2025, 01:00
by
User Not Found
Clinical Research News | Reunion Neuroscience will continue with its ongoing REKINDLE Phase 2 clinical trial in Adjustment Disorder (AjD) in cancer; Trially has launched Margo, an agentic AI solution that multiplies trial enrollment by converting patient matches into participants; and more.
Full story
-
Sep 23, 2025, 11:20
by
Certara on Sept. 22 launched a new capability in its Drug Interaction Database (DIDB) - the pharmaceutical industry’s largest scientist-curated collection of human in vitro and clinical data used to assess drug-drug interactions (DDIs) and safety - that allows researchers to rapidly identify medications that could impact a drug’s effects when taken together, allowing for safer and more intentional drug development.
Full story
-
Sep 23, 2025, 11:20
by
LabConnect has announced a strategic collaboration with The Bracken Group to expand its radiopharmaceutical support services, addressing fast-growing demand in the field. The partnership combines LabConnect’s global operational expertise with Bracken’s scientific and regulatory leadership, strengthening support for biotech and pharmaceutical companies developing targeted therapies and diagnostics. Together, the organizations aim to enhance capabilities in logistics, sample processing, and scientific oversight for complex radiopharmaceutical trials.
Full story
-
Sep 23, 2025, 11:20
by
Hunan Huateng Pharmaceutical Co., Ltd. provides 1-Methyl-1H-Pyrazole-4-Carboxylic Acid (CAS 5952-92-1), a high-purity intermediate used in the synthesis of Aficamten (CK-274), an investigational cardiac myosin inhibitor currently in Phase 3 trials for hypertrophic cardiomyopathy.
Full story
-
Sep 23, 2025, 01:00
by
User Not Found
Clinical Research News | Phage therapy, a treatment that uses viruses to fight bacterial infections, may finally be heading toward mainstream clinical practice. Paldara, a biotech startup, is developing a delivery platform that promises to stabilize and sustain bacteriophages and make phage therapy accessible for patients.
Full story
-
Sep 22, 2025, 09:46
by
Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, Pharma and Biotech Partners
Full story
-
Sep 22, 2025, 09:46
by
Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms
Full story